$DVLT

Why is Datavault AI stock sliding today?

Datavault AI Inc. (DVLT) stock fell 10.3% pre-market to $0.347 after reporting a widened net loss of $18.36M in Q2 2026, with revenue far below its $200M annual goal. The company raised $25M via a convertible note and 15M shares, fueling dilution concerns, and faces a $94.5M acquisition amid cash shortages. Nasdaq delisting risk and a lawsuit also weigh on the stock.

Original reporting
Published Aug 19, 2026, 10:43 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 10:52 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$DVLT
Bearish
high confidence
Mentioned
$DVLT
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$DVLTBearishHigh
01

Why it matters

The earnings miss and financing actions increase short‑term risk, but the acquisition could be a catalyst if executed.

02

Market read

The stock's steep pre‑market decline is driven by its own earnings and financing news, not broader market moves.

03

What to watch

Potential upside from Nasdaq bid‑price compliance if capital raise succeeds.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Datavault AI is a micro‑cap AI‑driven medtech company trading on Nasdaq.

Company-level read

Ticker impact

$DVLTBearishHigh confidence
Context

Q2 2026 results showed a widened net loss of $18.36M and a 10.3% pre‑market slide.

Expected impact

Further downside pressure in intraday trading.

Evidence & confidence

Loss expansion, debt extinguishment cost, and dilution raise capital adequacy concerns.

Market effects

Highlights financing challenges for micro‑cap AI medtech firms.

Limited to US small‑cap investors.

Minimal beyond niche AI/medtech sector.

Counterpoint

If the acquisition of CyberCatch delivers strategic value, the stock could rebound.

Key entities

  • Datavault AI Inc.

    AI‑focused medtech firm reporting Q2 2026 results.

  • Streeterville Capital

    Provider of a $25M convertible note and 15M shares.

  • CyberCatch Holdings

    Proposed $94.5M cash acquisition target.

Related articles

$DVLTMedAI 8/10

Datavault AI investors urged to act before Oct 5 class action deadline

Legal firms urge Datavault AI (DVLT) investors to act before the Oct 5, 2026, deadline for a class action lawsuit. The suit alleges the company made false statements about partnerships and trading volume between Sep 4, 2024, and Oct 30, 2025. Insiders sold shares worth $73.8M during this period, and the stock fell 19.44% after a critical report. DVLT also announced a $22M acquisition of WDT, LLC, parent of BankWyse, subject to regulatory approval.

HighAI 9/10

Datavault AI Inc. Q2 2026 Earnings Call Summary

Datavault AI Inc. reiterated its $200M revenue target for 2026, driven by its Data Science and Acoustic Science divisions. The company announced partnerships, acquisitions, and a $150M stock conversion to enhance its balance sheet. It plans to launch exchanges in mid-September 2026 and anticipates significant revenue growth in Q4, supported by $213M in signed contract fees. The company aims to avoid a reverse stock split by meeting revenue guidance and leveraging a shareholder equity exemption.

$DVLTHigh

Datavault AI (DVLT) Agrees $94.5 Million All Cash Acquisition

Datavault AI (DVLT) agreed to acquire CyberCatch for $94.5 million in cash. The deal, subject to approvals, will integrate CyberCatch's cybersecurity tech into Datavault's Quantum Private Network GPU ecosystem. Datavault reported a quarterly net loss of $88.03 million and faces execution and integration pressures.

$DVLTLow

Law Offices of Frank R. Cruz Encourages Datavault AI, Inc. (DVLT) Shareholders To Inquire About Securities Fraud Class Action

A class action lawsuit has been filed against Datavault AI, Inc. (DVLT) on behalf of shareholders who invested between September 4, 2024, and October 30, 2025. The lawsuit alleges securities fraud, claiming the company made false statements about its partnerships and platform activity. The stock price fell 19.44% on October 31, 2025, following a critical report by Wolfpack Research. Investors have until October 5, 2026, to file a lead plaintiff motion.

$DVLTMed

Bronstein, Gewirtz & Grossman LLC Urges Datavault AI Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC filed a class action lawsuit against Datavault AI Inc. (NASDAQ: DVLT) and its officers, alleging securities law violations. The lawsuit claims misstatements about partnerships, trading activity, and reputational harm. Investors who purchased shares between September 4, 2024, and October 30, 2025, are encouraged to join the case.